Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) is currently the treatment of choice for patients aged ≥75 years with severe aortic stenosis. Preoperative anemia is present in a large proportion of patients and may increase the risk of post-procedural complications. The purpose of this prognostic syst...

Descripción completa

Detalles Bibliográficos
Autores: Jiménez Xarrié, Elena|||0000-0003-3567-0672, Asmarats, Lluís|||0000-0002-3357-5834, Roqué i Figuls, Marta|||0000-0003-0043-1364, Millán, Xavier|||0000-0001-6519-4190, Li, Chi Hion|||0000-0001-7556-3711, Fernández-Peregrina, Estefanía|||0000-0002-3025-8251, Sánchez-Ceña, Juan|||0000-0002-7913-7813, Massó van Roessel, Albert|||0000-0003-1527-9019, Maestre Hittinger, M. Luz|||0000-0002-9193-9325, Paniagua, Pilar|||0000-0002-0215-1561, Arzamendi, Dabit|||0000-0001-7543-5867
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:300815
Acceso en línea:https://ddd.uab.cat/record/300815
https://dx.doi.org/urn:doi:10.3390/jcm12186025
Access Level:acceso abierto
Palabra clave:TAVR
Anemia
Aortic stenosis
Transcatheter aortic valve replacement
id ES_e4909cf82b5b22e6a3db1f0d01b1fc3a
oai_identifier_str oai:ddd.uab.cat:300815
network_acronym_str ES
network_name_str España
repository_id_str
spelling Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve ReplacementA Prognostic Systematic Review and Meta-AnalysisJiménez Xarrié, Elena|||0000-0003-3567-0672Asmarats, Lluís|||0000-0002-3357-5834Roqué i Figuls, Marta|||0000-0003-0043-1364Millán, Xavier|||0000-0001-6519-4190Li, Chi Hion|||0000-0001-7556-3711Fernández-Peregrina, Estefanía|||0000-0002-3025-8251Sánchez-Ceña, Juan|||0000-0002-7913-7813Massó van Roessel, Albert|||0000-0003-1527-9019Maestre Hittinger, M. Luz|||0000-0002-9193-9325Paniagua, Pilar|||0000-0002-0215-1561Arzamendi, Dabit|||0000-0001-7543-5867TAVRAnemiaAortic stenosisTranscatheter aortic valve replacementTranscatheter aortic valve replacement (TAVR) is currently the treatment of choice for patients aged ≥75 years with severe aortic stenosis. Preoperative anemia is present in a large proportion of patients and may increase the risk of post-procedural complications. The purpose of this prognostic systematic review was to analyze the impact of baseline anemia on short- and mid-term outcomes following TAVR. A computerized search was performed on PubMed and Web of Science databases for studies published between January 2013 and December 2022. Primary outcomes were 30-day need for transfusion, acute renal failure, 30-day and mid-term mortality, and readmission during the first year post-TAVR. Data were analyzed via random effects model using inverse variance method with 95% confidence intervals. Eleven observational studies met our eligibility criteria and included a total of 12,588 patients. The prevalence of baseline anemia ranged between 39% and 72%, with no relevant sex differences. Patients with preprocedural anemia received more blood transfusions [OR: 2.95 (2.13-4.09)]), and exhibited increased rates of acute kidney injury [OR:1.74 (1.45-2.10)], short-term mortality [OR: 1.47 (1.07-2.01], and mid-term [OR: 1.89 (1.58-2.25)] mortality following TAVR compared with those without anemia. Baseline anemia determined an increased risk for blood transfusion, acute kidney injury, and short/mid-term mortality among TAVR recipients.Universitat Autònoma de Barcelona 22023-01-0120232023-01-01Article de revisióhttp://purl.org/coar/resource_type/c_dcae04bcVoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/300815https://dx.doi.org/urn:doi:10.3390/jcm12186025reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3008152026-06-06T12:50:31Z
dc.title.none.fl_str_mv Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
A Prognostic Systematic Review and Meta-Analysis
title Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
spellingShingle Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
Jiménez Xarrié, Elena|||0000-0003-3567-0672
TAVR
Anemia
Aortic stenosis
Transcatheter aortic valve replacement
title_short Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
title_full Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
title_fullStr Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
title_full_unstemmed Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
title_sort Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement
dc.creator.none.fl_str_mv Jiménez Xarrié, Elena|||0000-0003-3567-0672
Asmarats, Lluís|||0000-0002-3357-5834
Roqué i Figuls, Marta|||0000-0003-0043-1364
Millán, Xavier|||0000-0001-6519-4190
Li, Chi Hion|||0000-0001-7556-3711
Fernández-Peregrina, Estefanía|||0000-0002-3025-8251
Sánchez-Ceña, Juan|||0000-0002-7913-7813
Massó van Roessel, Albert|||0000-0003-1527-9019
Maestre Hittinger, M. Luz|||0000-0002-9193-9325
Paniagua, Pilar|||0000-0002-0215-1561
Arzamendi, Dabit|||0000-0001-7543-5867
author Jiménez Xarrié, Elena|||0000-0003-3567-0672
author_facet Jiménez Xarrié, Elena|||0000-0003-3567-0672
Asmarats, Lluís|||0000-0002-3357-5834
Roqué i Figuls, Marta|||0000-0003-0043-1364
Millán, Xavier|||0000-0001-6519-4190
Li, Chi Hion|||0000-0001-7556-3711
Fernández-Peregrina, Estefanía|||0000-0002-3025-8251
Sánchez-Ceña, Juan|||0000-0002-7913-7813
Massó van Roessel, Albert|||0000-0003-1527-9019
Maestre Hittinger, M. Luz|||0000-0002-9193-9325
Paniagua, Pilar|||0000-0002-0215-1561
Arzamendi, Dabit|||0000-0001-7543-5867
author_role author
author2 Asmarats, Lluís|||0000-0002-3357-5834
Roqué i Figuls, Marta|||0000-0003-0043-1364
Millán, Xavier|||0000-0001-6519-4190
Li, Chi Hion|||0000-0001-7556-3711
Fernández-Peregrina, Estefanía|||0000-0002-3025-8251
Sánchez-Ceña, Juan|||0000-0002-7913-7813
Massó van Roessel, Albert|||0000-0003-1527-9019
Maestre Hittinger, M. Luz|||0000-0002-9193-9325
Paniagua, Pilar|||0000-0002-0215-1561
Arzamendi, Dabit|||0000-0001-7543-5867
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv TAVR
Anemia
Aortic stenosis
Transcatheter aortic valve replacement
topic TAVR
Anemia
Aortic stenosis
Transcatheter aortic valve replacement
description Transcatheter aortic valve replacement (TAVR) is currently the treatment of choice for patients aged ≥75 years with severe aortic stenosis. Preoperative anemia is present in a large proportion of patients and may increase the risk of post-procedural complications. The purpose of this prognostic systematic review was to analyze the impact of baseline anemia on short- and mid-term outcomes following TAVR. A computerized search was performed on PubMed and Web of Science databases for studies published between January 2013 and December 2022. Primary outcomes were 30-day need for transfusion, acute renal failure, 30-day and mid-term mortality, and readmission during the first year post-TAVR. Data were analyzed via random effects model using inverse variance method with 95% confidence intervals. Eleven observational studies met our eligibility criteria and included a total of 12,588 patients. The prevalence of baseline anemia ranged between 39% and 72%, with no relevant sex differences. Patients with preprocedural anemia received more blood transfusions [OR: 2.95 (2.13-4.09)]), and exhibited increased rates of acute kidney injury [OR:1.74 (1.45-2.10)], short-term mortality [OR: 1.47 (1.07-2.01], and mid-term [OR: 1.89 (1.58-2.25)] mortality following TAVR compared with those without anemia. Baseline anemia determined an increased risk for blood transfusion, acute kidney injury, and short/mid-term mortality among TAVR recipients.
publishDate 2023
dc.date.none.fl_str_mv 2
2023-01-01
2023
2023-01-01
dc.type.none.fl_str_mv Article de revisió
http://purl.org/coar/resource_type/c_dcae04bc
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/300815
https://dx.doi.org/urn:doi:10.3390/jcm12186025
url https://ddd.uab.cat/record/300815
https://dx.doi.org/urn:doi:10.3390/jcm12186025
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422602201595904
score 15.812429